154 related articles for article (PubMed ID: 35116423)
1. Effect of Babao Dan on angiogenesis of gastric cancer
Guan JH; Cao ZY; Guan B; Wei LH; Peng J; Chen YQ; Sferra TJ; Sankararaman S; Zhan ZX; Lin JM
Transl Cancer Res; 2021 Feb; 10(2):953-965. PubMed ID: 35116423
[TBL] [Abstract][Full Text] [Related]
2. Babao Dan inhibits lymphangiogenesis of gastric cancer in vitro and in vivo via lncRNA-ANRIL/VEGF-C/VEGFR-3 signaling axis.
Guan J; Guan B; Shang H; Peng J; Yang H; Lin J
Biomed Pharmacother; 2022 Oct; 154():113630. PubMed ID: 36058147
[TBL] [Abstract][Full Text] [Related]
3. Babao Dan inhibits the migration and invasion of gastric cancer cells by suppressing epithelial-mesenchymal transition through the TGF-β/Smad pathway.
Liu J; Chen Y; Cao Z; Guan B; Peng J; Chen Y; Zhan Z; Sferra TJ; Sankararaman S; Lin J
J Int Med Res; 2020 Jun; 48(6):300060520925598. PubMed ID: 32529872
[TBL] [Abstract][Full Text] [Related]
4. c-Jun N-terminal kinase mediated VEGFR2 sustained phosphorylation is critical for VEGFA-induced angiogenesis in vitro and in vivo.
Shen K; Ji L; Lu B; Wang Z
Cell Biochem Biophys; 2012 Sep; 64(1):17-27. PubMed ID: 22592917
[TBL] [Abstract][Full Text] [Related]
5. ACE2 inhibits breast cancer angiogenesis via suppressing the VEGFa/VEGFR2/ERK pathway.
Zhang Q; Lu S; Li T; Yu L; Zhang Y; Zeng H; Qian X; Bi J; Lin Y
J Exp Clin Cancer Res; 2019 Apr; 38(1):173. PubMed ID: 31023337
[TBL] [Abstract][Full Text] [Related]
6. Cryptotanshinone inhibits VEGF-induced angiogenesis by targeting the VEGFR2 signaling pathway.
Xu X; Wu L; Zhou X; Zhou N; Zhuang Q; Yang J; Dai J; Wang H; Chen S; Mao W
Microvasc Res; 2017 May; 111():25-31. PubMed ID: 28040437
[TBL] [Abstract][Full Text] [Related]
7. Helicobacter pylori-induced fibroblast-derived Serpin E1 promotes gastric cancer growth and peritoneal dissemination through p38 MAPK/VEGFA-mediated angiogenesis.
Cheng W; Liao Y; Xie Y; Wang Q; Li L; Chen Y; Zhao Y; Zhou J
Cancer Cell Int; 2023 Dec; 23(1):326. PubMed ID: 38104099
[TBL] [Abstract][Full Text] [Related]
8. Long noncoding TUG1 promotes angiogenesis of HUVECs in PE via regulating the miR-29a-3p/VEGFA and Ang2/Tie2 pathways.
Liu Z; Guo N; Zhang XJ
Microvasc Res; 2022 Jan; 139():104231. PubMed ID: 34352236
[TBL] [Abstract][Full Text] [Related]
9. Dual blockade of VEGFR1 and VEGFR2 by a novel peptide abrogates VEGF-driven angiogenesis, tumor growth, and metastasis through PI3K/AKT and MAPK/ERK1/2 pathway.
Sadremomtaz A; Mansouri K; Alemzadeh G; Safa M; Rastaghi AE; Asghari SM
Biochim Biophys Acta Gen Subj; 2018 Dec; 1862(12):2688-2700. PubMed ID: 30251659
[TBL] [Abstract][Full Text] [Related]
10. Activating CD137 Signaling Promotes Sprouting Angiogenesis via Increased VEGFA Secretion and the VEGFR2/Akt/eNOS Pathway.
Li B; Zhang Y; Yin R; Zhong W; Chen R; Yan J
Mediators Inflamm; 2020; 2020():1649453. PubMed ID: 33162828
[TBL] [Abstract][Full Text] [Related]
11. MiR-203 Participates in Human Placental Angiogenesis by Inhibiting VEGFA and VEGFR2 Expression.
Liu F; Wu W; Wu K; Chen Y; Wu H; Wang H; Zhang W
Reprod Sci; 2018 Mar; 25(3):358-365. PubMed ID: 28826364
[TBL] [Abstract][Full Text] [Related]
12. The anti-angiogenic action of 2-deoxyglucose involves attenuation of VEGFR2 signaling and MMP-2 expression in HUVECs.
Chuang IC; Yang CM; Song TY; Yang NC; Hu ML
Life Sci; 2015 Oct; 139():52-61. PubMed ID: 26285173
[TBL] [Abstract][Full Text] [Related]
13. Low dosage of arsenic trioxide (As
Luo D; Zhang X; Du R; Gao W; Luo N; Zhao S; Li Y; Chen R; Wang H; Bao Y; Yang W; Liu D; Shen W
J Biol Inorg Chem; 2018 Aug; 23(6):939-947. PubMed ID: 30014256
[TBL] [Abstract][Full Text] [Related]
14. Circ-100290 Positively Regulates Angiogenesis Induced by Conditioned Medium of Human Amnion-Derived Mesenchymal Stem Cells Through miR-449a/eNOS and miR-449a/VEGFA Axes.
Tang Z; Wu X; Hu L; Xiao Y; Tan J; Zuo S; Shen M; Yuan X
Int J Biol Sci; 2020; 16(12):2131-2144. PubMed ID: 32549760
[TBL] [Abstract][Full Text] [Related]
15. MART-10, the new brand of 1α,25(OH)2D3 analog, is a potent anti-angiogenic agent in vivo and in vitro.
Chiang KC; Sun CC; Chen MH; Huang CY; Hsu JT; Yeh TS; Chen LW; Kuo SF; Juang HH; Takano M; Kittaka A; Chen TC; Yeh CN; Pang JH
J Steroid Biochem Mol Biol; 2016 Jan; 155(Pt A):26-34. PubMed ID: 26385607
[TBL] [Abstract][Full Text] [Related]
16. Knockdown of lncRNA TUG1 suppresses corneal angiogenesis through regulating miR-505-3p/VEGFA.
Liu S; Gao J; Chen J
Microvasc Res; 2021 Nov; 138():104233. PubMed ID: 34411571
[TBL] [Abstract][Full Text] [Related]
17. Mitofusin-2 is a novel anti-angiogenic factor in pancreatic cancer.
Lin Z; Lin X; Chen J; Huang G; Chen T; Zheng L
J Gastrointest Oncol; 2021 Apr; 12(2):484-495. PubMed ID: 34012642
[TBL] [Abstract][Full Text] [Related]
18. Evodiamine exerts anti-tumor effects against hepatocellular carcinoma through inhibiting β-catenin-mediated angiogenesis.
Shi L; Yang F; Luo F; Liu Y; Zhang F; Zou M; Liu Q
Tumour Biol; 2016 Sep; 37(9):12791-12803. PubMed ID: 27449032
[TBL] [Abstract][Full Text] [Related]
19. The long noncoding RNA PDK1-AS/miR-125b-5p/VEGFA axis modulates human dermal microvascular endothelial cell and human umbilical vein endothelial cell angiogenesis after thermal injury.
Zhou S; Liang P; Zhang P; Zhang M; Huang X
J Cell Physiol; 2021 Apr; 236(4):3129-3142. PubMed ID: 33078418
[TBL] [Abstract][Full Text] [Related]
20. Knockdown of growth factor receptor bound protein 7 suppresses angiogenesis by inhibiting the secretion of vascular endothelial growth factor A in ovarian cancer cells.
Xu Q; Liu Z; Zhu ZQ; Fan Y; Chen R; Xie XH; Cheng M
Bioengineered; 2021 Dec; 12(2):12179-12190. PubMed ID: 34783299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
